Monitoring population levels of alcohol consumption in pregnant women: A case for using biomarkers

Substance Use and Misuse

Volumn 48, Issue 8, 2013, Pages 569-573

  Shipton, Deborah ^a   Tappin, David ^a   Sherwood, Roy ^b   MacTier, Helen ^c   Aitken, David ^d   Crossley, Jenny ^d  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c Princess Royal Maternity ^*  (United Kingdom)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Alcohol consumption; Baseline; Biomarkers; Monitoring; Pregnancy

Indexed keywords

BIOLOGICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; CARBOHYDRATE-DEFICIENT TRANSFERRIN; DRUG DERIVATIVE; ETHYL GLUCURONIDE; GLUCURONIC ACID; TRANSFERRIN;

ADULT; ARTICLE; BLOOD; DRINKING BEHAVIOR; FEASIBILITY STUDY; FEMALE; HEALTH SURVEY; HUMAN; METABOLISM; METHODOLOGY; PILOT STUDY; PREGNANCY; SUBSTANCE ABUSE;

ADULT; ALCOHOL DRINKING; BIOLOGICAL MARKERS; FEASIBILITY STUDIES; FEMALE; GLUCURONATES; HUMANS; PILOT PROJECTS; POPULATION SURVEILLANCE; PREGNANCY; SUBSTANCE ABUSE DETECTION; TRANSFERRIN;

EID: 84879162906     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2013.786730     Document Type: Article

References (24)

1. Anton, R. F. (2001). Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned Where do we go from here. Alcohol, 25, 185-188.
2. Beeston, C., Robinson, M., Craig, N., & Graham, L. (2011). Monitoring and evaluating Scotland's alcohol strategy. Setting the scene: Theory of change and baseline picture. Edinburgh: NHS Health Scotland.
3. Bianchi,V., Ivaldi, A., Raspagni,A., Arfini, C.,&Vidali, M. (2011). Pregnancy and variations of carbohydrate-deficient transferrin levels measured by the candidate reference HPLC method. Alcohol and Alcoholism, 46, 123-127.
4. Bortolotti, F., De Paoli, G., & Tagliaro, F. (2006). Carbohydratedeficient transferrin (CDT) as a marker of alcohol abuse: A critical review of the literature 2001-2005. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 841, 96-109.
5. Burns, E.,Gray, R.,&Smith, L.A. (2010). Brief screening questionnaires to identify problem drinking during pregnancy: A systematic review. Addiction, 105, 601-614.
6. Cook, J. D. (2003). Biochemical markers of alcohol use in pregnant women. Clinical Biochemistry, 36, 9-19.
7. Dawson, D. A., & Room, R. (2000). Towards agreement on ways to measure and report drinking patterns and alcohol-related problems in adult general population surveys: The Skarp̈o conference overview. Journal of Substance Abuse, 12, 1-21.
8. Denny, C., Tsai, J., Floyd, R., & Green, P. (2009). Alcohol use among pregnant and nonpregnant women of childbearing age-United States, 1991-2005. Morbidity and Mortality Weekly Report, 58(19), 529-532.
9. Ebrahim, S. H., Luman, E. T., Floyd, R. L.,Murphy, C. C., Bennett, E. M., & Boyle, C.A. (1998). Alcohol consumption by pregnant women in the United States during 1988-1995. Obstetrics and Gynecology, 92, 187-192.
10. Greater Glasgow and Clyde NHS Board (2012). Public health screening programmes annual report (1st April 2010-31st March 2011). Glasgow.
11. Greenfield, T. K., & Kerr, W. C. (2008). Alcohol measurement methodology in epidemiology: Recent advances and opportunities. Addiction, 103, 1082-1099.
12. Heeb, J., & Gmel, G. (2005). Measuring alcohol consumption: A comparison of graduated frequency, quantity frequency, and weekly recall diary methods in a general population survey. Addictive Behaviors, 30, 403-413.
13. Kalapatapu, R. K., & Chambers, R. (2009). Novel objective biomarkers of alcohol use: Potential diagnostic and treatment management tools in dual diagnosis care. Journal of Dual Diagnosis, 5, 57-82.
14. Litten, R. Z., Bradley, A. M., & Moss, H. B. (2010). Alcohol biomarkers in applied settings: Recent advances and future research opportunities. Alcoholism, Clinical and Experimental Research, 34, 955-967.
15. Littner, Y., & Bearer, C. F. (2007). Detection of alcohol consumption during pregnancy-current and future biomarkers. Neuroscience and Biobehavioral Reviews, 31, 261-269.
16. May, P. A.,&Gossage, J. P. (2001). Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Research & Health, 25, 159-167.
17. Miller, P. M.,&Anton, R. F. (2004). Biochemical alcohol screening in primary health care. Addictive Behaviors, 29, 1427-1437.
18. Stade, B., Ali, A., Bennett, D., Campbell, D., Johnston, M., Lens, C., et al. (2009). The burden of prenatal exposure to alcohol: Revised measurement of cost. The Canadian Journal of Clinical Pharmacology, 16, e91-102.
19. The Scottish Government (2009). Changing Scotland's relationship with alcohol: A framework for action. Edinburgh: Scottish Government.
20. Walsham, N. E., & Sherwood, R. A. (2012). Ethyl glucuronide. Annals of Clinical Biochemistry, 49, 110-117.
21. Whyte, B., & Ajetunmobi, T. (2012). Still "the sick man of Europe": Scottish mortality in a European context, 1950 to 2010. Glasgow: Glasgow Centre for Population Health .
22. Wojcik, M. H., & Hawthorne, J. S. (2007). Sensitivity of commercial ethyl glucuronide (ETG) testing in screening for alcohol abstinence. Alcohol and Alcoholism, 42, 317-320.
23. Wollf,K., Gross S.Marshall E.WalshamN.DuraniN.Keaney F. et al. (2010). Road Safety Research Report No. 104: The role of carbohydrate deficient transferrin as an alternative to gamma glutamyl transferase as a marker of continuous drinking in highrisk drivers. London: Department of Transport.
24. Wurst, F. M., Kelso, E., Weinmann, W., Pragst, F., Yegles, M., & Sundstr̈om Poromaa, I. (2008). Measurement of direct ethanol metabolites suggests higher rate of alcohol use among pregnant women than found with the AUDIT-a pilot study in a population-based sample of Swedish women. American Journal of Obstetrics and Gynecology, 198, 407.e1-407.e5.